 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
tetracycline
 
Attending: ___.
 
Chief Complaint:
Sepsis
 
Major Surgical or Invasive Procedure:
None this hospitalization.
 
History of Present Illness:
___ is a ___ yo woman with metastatic (lung) 
recurrence of Stage IA (ypT1N0M0) PDAC (pancreatic CA) s/p 
neoadjuvant FOLFIRINOX, SBRT, Whipple (___), adjuvant 
FOLFOX, on Phase ___ DF/___ ___ trial, who presents with 
fever and found to have GNR bacteremia and e coli UTI.

She was feeling well until ___ (2 days PTA) when she felt 
feverish and spiked a temperature to Tmax 101.3F. She presented 
to ___ the next morning (___) and received infectious 
workup including BCx, UCx, flu, strep, CXR, which were 
preliminarily negative. She was discharged home, but called back 
in late in the evening when ___ BCx turned positive for GNRs.

At ___-P, she received a CT A/P which did not show any 
intraabdominal source of infection. UCx at that time was no 
growth, but later it turned positive for >100,000 cfu e coli. 
She was started on zosyn and transferred to ___ for further 
management.

In the ___ ED: T ___ F | 95 | 126/82 | 97% RA. She received IV 
zosyn prior to admission.

When seen at bedside, Mrs. ___ reports a ___ frontal and 
posterior headache, which she attributes to fatigue and says has 
been intermittent since the initiation of chemotherapy. She also 
has some mild back and chest pain, which she gets routinely 
after G-CSF (received neulasta yesterday). She also reports she 
has some abdominal discomfort and had 1 loose bowel movement per 
day over the last 2 days. She otherwise denies n/v, recurrent 
fever, chills, sweats, dysuria, cloudy urine, cough, cold 
symptoms (has chronic congestion for months, but no sore throat, 
rhinorrhea). No sick contacts, no suspicious food intake.

All other review of systems are negative unless stated 
otherwise.
 
Past Medical History:
Metastatic recurrence of pancreatic cancer: Presented with 
transaminitis and malignant CBD stricture ___. CTA showed 1.4 
cm pancreatic head mass. She received 3 cycles of neoadjuvant 
FOLFIRINOX (___), followed by SBRT (___), 
and then Whipple ___. Her final pathologic staging was T1N0 
(1.3 cm PDAC in head of pancreas; ___ nodes, negative margins, 
+ PNI and grade II large vessel angiolymphatic invasion). She 
received 3 cycles of adjuvant FOLFOX (___). In ___, CT 
torso showed multiple subcm pulmonary nodules, which were noted 
to increase on follow up CTs ___ and ___. A lung biopsy 
confirmed metastatic disease ___ and she was consented and 
started on Phase ___ open label trial of RX-___ in combination 
with abraxane at ___. C1D1 ___. 

Hyperlipidemia 
Hypothyroidism
GERD
depression
nephrolithiasis
Remote eye surgery to correct strabismus she had when she was
a child
hx right breast ALH ___ s/p excision at OSH
dry eyes
dry mouth since chemotherapy
 
Social History:
___
Family History:
She notes that her mother had an episode of "jaundice" at ___ or 
___ years, was diagnosed with colon cancer at age ___, and died 6 
months later. Grandmother died from "septicemia," abdominal 
causes. She is ___ of five children, all in good health. Sister 
with ___ disease. 
 
Physical Exam:
========================
Admission Physical Exam:
========================
VITALS: T 98.6 F | 139/76 | 73 | 95% RA
General: Well appearing pleasant Caucasian woman, sitting up in 
bed.
Neuro: Alert, oriented to person, place and time, provides clear 
and cogent history.
HEENT: Oropharynx clear, MMM, no palpable cervical or 
supraclavicular adenopathy, no sinus tenderness to palpation.
Cardiovascular: RRR, soft ___ systolic murmur.
Chest/Pulmonary: Clear to auscultation bilaterally.
Abdomen: Soft, nontender, nondistended, bowel sounds present.
Back: No CVA tenderness.
Extr/MSK: No peripheral edema.
Skin: No rashes on torso, arms, legs.
Access: R POC is c/d/I and nontender to palpation.

========================
Discharge Physical Exam:
========================
VS: Temp 98.1, BP 119/70, HR 70, RR 20, O2 sat 96% RA.
Exam otherwise unchanged.
 
Pertinent Results:
===============
Admission Labs:
===============
___ 02:00PM BLOOD WBC-7.0 RBC-2.59* Hgb-8.1* Hct-24.2* 
MCV-93 MCH-31.3 MCHC-33.5 RDW-16.7* RDWSD-55.6* Plt ___
___ 02:00PM BLOOD Neuts-82.1* Lymphs-11.0* Monos-4.9* 
Eos-1.6 Baso-0.1 Im ___ AbsNeut-5.72 AbsLymp-0.77* 
AbsMono-0.34 AbsEos-0.11 AbsBaso-0.01
___ 12:56PM BLOOD Glucose-85 UreaN-13 Creat-0.7 Na-140 
K-4.0 Cl-105 HCO3-23 AnGap-12
___ 05:31AM BLOOD ALT-21 AST-23 AlkPhos-57 TotBili-0.4

===============
Discharge Labs:
===============
___ 05:31AM BLOOD Calcium-8.8 Phos-3.4 Mg-1.9
___ 06:00AM BLOOD WBC-22.9* RBC-2.66* Hgb-8.3* Hct-25.5* 
MCV-96 MCH-31.2 MCHC-32.5 RDW-17.9* RDWSD-59.7* Plt ___
___ 06:00AM BLOOD Glucose-85 UreaN-13 Creat-0.8 Na-142 
K-4.0 Cl-103 HCO3-25 AnGap-14

=============
Microbiology:
=============
___ Group A Strep Throat at ___: Rapid Antigen - 
Negative; Culture - Pending
___ Influenza A/B PCR at ___ - Negative
___ Blood Culture x 2 at ___ - Klebsiella 
Pneumoniae
___ Urine Culture at ___ - E. Coli
___ Blood Culture x 2 at ___ - Pending

___ Influenza A/B PCR - Negative
___ Urine Culture - Pending
___ Blood Culture x 2 - Pending

========
Imaging:
========
CXR ___ at ___
Impression: Unchanged and no evidence of active disease.

CT Abdomen/Pelvis w/ Contrast ___ at ___
Impression: Bilateral pulmonary nodules are noted for which 
follow-up chest CT is recommended to evaluate for stability. No 
acute abdominal pelvic process is identified.
 
Brief Hospital Course:
Ms. ___ is a ___ woman with metastatic 
pancreatic cancer s/p neoadjuvant FOLFIRINOX, SBRT, Whipple 
(___), adjuvant FOLFOX, and currently on Phase ___ DF/___ 
___ trial who presents with fever and found to have GNR 
bacteremia and E. coli UTI.

# Sepsis Secondary to Klebsiella Bacteremia: Culture data from 
___. 1 of 4 blood cultures growing Klebsiella. Potentially 
transient bacteremia from biliary
source. Received CT A/P at ___ which did not show 
intraabdominal abscess. Her cultures cleared and she was feeling 
well. She had some mild diarrhea that was negative for C. diff. 
She was discharged to complete a 14-day course of ciprofloxacin 
(Day ___, to be completed ___.

# E. Coli UTI: Urine growing E. coli but patient asymptomatic 
and UA unimpressive. Likely asymptomatic bacteriuria but 
regardless will be treated by cipro as above.

# Metastatic Pancreatic Adenocarcinoma:
# Secondary Neoplasm of Lung: Currently on Phase ___ trial 
___ of RX-3117 (oral cytidine analogue) + abraxane; last 
received C3D8 on ___. She received Neulasta at ___ on 
___. Continued home creon, Ativan, and Zofran. Will follow-up 
in clinic.

# Anemia: Secondary to malignancy and chemotherapy.

# Leukocytosis: Likely secondary to Neulasta which she receiving 
at ___. No elevated WBC on initial presentation.

# HLP: Continued home colesevelam.
# Hypothyroidism: Continued home levothyroxine.
# GERD: Continued home omeprazole.
# Depression: Continued home venlafaxine.

# BILLING: 35 minutes were spent in preparation of discharge 
summary and coordination with outpatient providers.

====================
Transitional Issues:
====================
- Patient discharged to complete a 14-day course of 
ciprofloxacin (Day ___, to be completed ___.
- Please follow-up pending blood cultures from ___ on ___.
- Please follow-up multiple pending blood cultures from 
___ on ___.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. colesevelam 625 mg oral BID
2. Levothyroxine Sodium 125 mcg PO DAILY
3. LORazepam 0.5 mg PO Q8H:PRN anxiety, nausea
4. Omeprazole 40 mg PO DAILY
5. Ondansetron ODT 8 mg PO Q8H:PRN Nausea/Vomiting - First Line
6. Venlafaxine XR 150 mg PO DINNER
7. Vitamin D ___ UNIT PO DAILY
8. coenzyme Q10 200 mg oral DAILY
9. Docusate Sodium 100 mg PO BID:PRN Constipation - First Line
10. Senna 8.6 mg PO BID:PRN Constipation - First Line
11. Multivitamins 1 TAB PO DAILY
12. Fish Oil (Omega 3) 1000 mg PO DAILY
13. turmeric 1  capsule oral DAILY
14. Creon (lipase-protease-amylase) ___ unit 
oral TID W/MEALS
 
Discharge Medications:
1.  Ciprofloxacin HCl 500 mg PO Q12H
Plan for 14-day course (Day ___, to be completed ___.
RX *ciprofloxacin HCl 500 mg Take 1 tablet by mouth twice daily. 
Disp #*22 Tablet Refills:*0
2.  coenzyme Q10 200 mg oral DAILY
3.  colesevelam 625 mg oral BID
4.  Creon (lipase-protease-amylase) ___ unit 
oral TID W/MEALS
5.  Docusate Sodium 100 mg PO BID:PRN Constipation - First Line
6.  Fish Oil (Omega 3) 1000 mg PO DAILY
7.  Levothyroxine Sodium 125 mcg PO DAILY
8.  LORazepam 0.5 mg PO Q8H:PRN anxiety, nausea
9.  Multivitamins 1 TAB PO DAILY
10.  Omeprazole 40 mg PO DAILY
11.  Ondansetron ODT 8 mg PO Q8H:PRN Nausea/Vomiting - First 
Line
12.  Senna 8.6 mg PO BID:PRN Constipation - First Line
13.  turmeric 1  capsule oral DAILY
14.  Venlafaxine XR 150 mg PO DINNER
15.  Vitamin D ___ UNIT PO DAILY
 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary Diagnosis:
- Sepsis Secondary to Klebsiella Bacteremia
- E. Coli Urinary Tract Infection
- Metastatic Pancreatic Adenocarcinoma
- Secondary Neoplasm of Lung
- Anemia
- Leukocytosis
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you at the ___ 
___. You were admitted to the hospital with 
a fever. You were found to have a bacteria in your blood called 
Klebsiella. Fortunately this bacteria can be treated with 
multiple antibiotics including oral antibiotics. Also only one 
of the blood cultures grew bacteria and the rest have remained 
negative. You were discharged on ciprofloxacin to complete a 
2-week course. You can start taking the antibiotic on ___ 
morning.

You also had a CAT scan of your abdomen and a chest x-ray at 
___ that did now show any cause of the infection.

Please continue your prior home medications.

Please follow-up with your outpatient team.

All the best,
Your ___ Team
 
Followup Instructions:
___
